ArticleScientific reports2025
Analysis of optic neuritis risk in patients with allergic diseases.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The association between allergic diseases and optic neuritis (ON) remains insufficiently characterized. This nationwide cohort study investigated the relationship between major allergic diseases (atopic dermatitis, asthma, and allergic rhinitis) and the risk of ON development. We performed a population-based cohort study utilizing data from the Korean National Health Insurance Service database. The study included 4,052,827 individuals aged 20 years or older who participated in health screenings in 2009. All participants were monitored until December 2018 or until ON diagnosis. Cox proportional hazards models were applied to estimate hazard ratios (HRs) for ON, adjusting for relevant confounders. Over a median follow-up duration of 8.2 years, 3,640 individuals (0.09%) were diagnosed with ON. After adjusting for confounders, individuals with allergic diseases exhibited a statistically significant increased ON risk compared to those without allergic diseases (adjusted HR 1.317, 95% confidence interval [CI] 1.216-1.426, p < 0.0001). Among the specific allergic diseases, allergic rhinitis showed the highest association (adjusted HR 1.335, 95% CI 1.229-1.450, p < 0.0001), whereas asthma and atopic dermatitis did not demonstrate statistically significant associations after adjustment. These results highlight potential common pathogenic mechanisms and underscore the importance of future studies to clarify the biological pathways connecting allergic diseases and ON.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.